top of page
Publications
Read Peer-Reviewed Publications on the Development of our Technology
MiSelect R System: the validation of a new detection system of CTCs and their correlation with prognosis in non-metastatic CRC patients (2023)
Isolating Rare Cells and Circulating Tumor Cells with High Purity by Sequential eDAR (2019)
Simultaneous and selective isolation of multiple subpopulations of rare cells from peripheral blood using ensemble-decision aliquot ranking (eDAR) (2015)
New Generation of Ensemble-Decision Aliquot Ranking Based on Simplified Microfluidic Components for Large-Capacity Trapping of Circulating Tumor Cells (2013)
An Automated High-Throughput Counting Method for Screening Circulating Tumor Cells in Peripheral Blood (2013)
Sensitive and High‐Throughput Isolation of Rare Cells from Peripheral Blood with Ensemble‐Decision Aliquot Ranking (2012)
Read How MiCareo's Products are Enabling New Discoveries
Beyond the Blood-Brain Barrier: Feasibility and Technical Validation of Dual-Compartment Circulating Tumor Cells Detection in High-Grade Glioma Patients (2025)
Tracking B Cell Memory to SARS-CoV-2 Using Rare Cell Analysis System (2023)
Enhanced prognostic value of combined circulating tumor cells and serum carcinoembryonic antigen in patients with colorectal cancer (2023)
STAT3-coordinated migration facilitates the dissemination of diffuse large B-cell lymphomas (2018)
bottom of page















